In vivo CAR-T therapy aims to turn bespoke living drugs into universal genetic medicines
A new review charts how in vivo CAR-T engineering could transform customized living drugs into scalable, off-the-shelf genetic medicines.
A new review charts how in vivo CAR-T engineering could transform customized living drugs into scalable, off-the-shelf genetic medicines.
Scientists have developed an mRNA delivery system that can generate functional chimeric antigen receptor (CAR) T cells inside the body ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine